INCB-057643 Uses, Dosage, Side Effects and more
INCB-057643 is under investigation in clinical trial NCT02959437 (Azacitidine Combined With Pembrolizumab and Epacadostat in Subjects With Advanced Solid Tumors (ECHO-206)).
| Trade Name | INCB-057643 |
| Generic | INCB-057643 |
| Type | |
| Formula | C20H21N3O5S |
| Weight | Average: 415.46 Monoisotopic: 415.120191962 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
